Article

B&L shareholders OK Warburg Pincus merger

Bausch & Lomb (B&L) shareholders have approved the proposed merger of the company with affiliates of Warburg Pincus LLC, according to the company.

Rochester, NY-Bausch & Lomb (B&L) shareholders have approved the proposed merger of the company with affiliates of Warburg Pincus LLC, according to the company.

"We look forward to completing the transaction promptly," said Ronald L. Zarrella, B&L chairman and chief executive officer.

The transaction is expected to close early in the fourth quarter. Each outstanding share of B&L common and Class B stock will be canceled and converted into the right to receive $65 in cash, without interest and minus any applicable withholding taxes.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
© 2025 MJH Life Sciences

All rights reserved.